Clinical Trials Browser

NCT03422731 2026-03-16

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

Phase EARLY_PHASE1 Recruiting

74 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06765876 2026-01-12

UHKT-CAR123-01

Phase EARLY_PHASE1 Recruiting

18 enrolled

LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07059975 2025-11-04

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Phase EARLY_PHASE1 Recruiting

36 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07144020 2025-08-27

Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

50 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07126782 2025-08-17

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

Phase EARLY_PHASE1 Recruiting

10 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06980155 2025-05-20

XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

60 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06201247 2025-03-11

Off-the-shelf CD123 CAR-NK for R/R AML

Phase EARLY_PHASE1 Recruiting

12 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06762132 2025-01-07

A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

27 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06642025 2024-10-15

EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

9 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06541405 2024-08-07

Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

9 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06541444 2024-08-07

Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

9 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04662294 2021-11-04

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases

Phase EARLY_PHASE1 Recruiting

108 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute